Clinical Study
Profile of Microbial Keratitis after Corneal Collagen Cross-Linking
Table 1
Clinical profile of patients who developed keratitis after collagen cross-linking.
| Clinical profile (Age/Sex) |
Associated conditions and treatment for the same duration | Preoperative BCVA | Procedure | Day of presentation of symptoms from day of surgery | Treatment | Time for resolution of symptoms | Rehabilitation | Final BCVA |
| Patient 1 (27/F) | Bronchial asthma (12 years) | Oral/Inhalational steroids (12 years) | 20/30 | Conventional CXL | 3 | Fortified antibiotics | 6 weeks | FEK | 20/20 | Patient 2 (18/M) | Vernal catarrh (10 years) | Topical steroids (10 years) | 20/20 | Conventional CXL | 3 | Fortified antibiotics | 4 weeks | RGP | 20/30 | Patient 3 (25/M) | Eczema (5 years) | Oral cyclophosphamide (5 years) | 20/20 | Conventional CXL | 3 | Fortified antibiotics | 5 weeks | Advised PKP | 20/120 | Patient 4 (16/M) | Vernal catarrh (6 years) | Topical steroids (6 years) | 20/20 | Conventional CXL | 3 | Fortified antibiotics | 5 weeks | AMG, under follow-up | 20/200 |
|
|
M: male, F: female, BCVA: best corrected visual acuity, FEK: femtosecond enabled penetrating keratoplasty, PKP: penetrating keratoplasty, RGP: rigid gas permeable lens, and AMG: amniotic membrane grafting.
|